Nemolizumab for treating prurigo nodularis [ID6451]
In development
Reference number: GID-TA11566
Expected publication date:
Please note ID6451 indication is now a separate appraisal from ID6221 indication. The appraisal will be running on the same timelines as ID6221. Please see relevant topic webpages for further information.